Home » Topics » BioWorld Science

BioWorld Science
RSS

NDA submission for King's injectable estrogen replacement therapy

Nov. 6, 2001

Canadian neuroprotection research collaboration announced

Nov. 6, 2001

SGLT2 inhibitors from Kissei useful for diabetes, obesity

Nov. 5, 2001

Kitastato team discovers FKI-0076, a naturally produced antifungal enhancer

Nov. 5, 2001

Dainippon synthesizes pyridonecarboxylic acid antibacterial agents

Nov. 5, 2001

Pyrimidinone-based GSK3beta inhibitors and uses described by Sanofi-Synthelabo

Nov. 5, 2001

Preparation and use of 1,5-benzothiazepines that inhibit bile acid transport

Nov. 5, 2001

New agents for osteoporosis in the AxyS pipeline

Nov. 5, 2001

Merck scientists identify peptidomimetic compounds for Alzheimer's disease

Nov. 5, 2001

Pharmacyclics offers update of products in advanced clinical trials

Nov. 5, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...